 Jose Diaz-Miron
Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracorporeal Membrane Oxygenation | 2 | 2025 | 345 | 1.390 |
Why?
| | Intestine, Small | 8 | 2017 | 157 | 1.130 |
Why?
| | Appendicitis | 3 | 2025 | 146 | 1.080 |
Why?
| | Surgeons | 5 | 2023 | 336 | 1.050 |
Why?
| | Gastrostomy | 5 | 2026 | 122 | 0.880 |
Why?
| | Central Venous Catheters | 1 | 2023 | 51 | 0.800 |
Why?
| | Renal Insufficiency | 1 | 2025 | 169 | 0.790 |
Why?
| | Intestinal Atresia | 1 | 2023 | 15 | 0.790 |
Why?
| | Needs Assessment | 1 | 2025 | 385 | 0.770 |
Why?
| | Catheter-Related Infections | 1 | 2023 | 92 | 0.770 |
Why?
| | Clinical Decision-Making | 1 | 2025 | 339 | 0.740 |
Why?
| | Catheterization, Central Venous | 1 | 2023 | 116 | 0.730 |
Why?
| | Myofibromatosis | 1 | 2021 | 9 | 0.730 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2025 | 328 | 0.710 |
Why?
| | Funnel Chest | 3 | 2026 | 28 | 0.700 |
Why?
| | Heart Arrest | 1 | 2025 | 385 | 0.690 |
Why?
| | Decision Making | 2 | 2025 | 961 | 0.650 |
Why?
| | Minimally Invasive Surgical Procedures | 3 | 2026 | 181 | 0.640 |
Why?
| | Adaptation, Physiological | 6 | 2017 | 562 | 0.630 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 408 | 0.570 |
Why?
| | Infant, Newborn | 8 | 2025 | 6289 | 0.540 |
Why?
| | Wounds and Injuries | 2 | 2024 | 897 | 0.540 |
Why?
| | Neovascularization, Physiologic | 3 | 2015 | 182 | 0.530 |
Why?
| | Short Bowel Syndrome | 5 | 2017 | 27 | 0.480 |
Why?
| | Child | 22 | 2026 | 22414 | 0.470 |
Why?
| | Retrospective Studies | 18 | 2026 | 16374 | 0.450 |
Why?
| | Lung Diseases | 1 | 2022 | 793 | 0.450 |
Why?
| | Coronary Aneurysm | 1 | 2014 | 14 | 0.430 |
Why?
| | Quality Improvement | 1 | 2023 | 1254 | 0.430 |
Why?
| | Appendectomy | 2 | 2025 | 89 | 0.420 |
Why?
| | Hepatoblastoma | 2 | 2024 | 47 | 0.410 |
Why?
| | Thoracic Injuries | 1 | 2014 | 67 | 0.410 |
Why?
| | Baseball | 1 | 2014 | 55 | 0.410 |
Why?
| | Telemedicine | 2 | 2025 | 894 | 0.400 |
Why?
| | Specialties, Surgical | 2 | 2025 | 80 | 0.400 |
Why?
| | Hemostasis | 1 | 2013 | 98 | 0.390 |
Why?
| | Hematopoiesis | 1 | 2013 | 194 | 0.380 |
Why?
| | Surgical Wound Infection | 2 | 2026 | 321 | 0.370 |
Why?
| | Wounds, Nonpenetrating | 1 | 2014 | 307 | 0.340 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3737 | 0.340 |
Why?
| | Postoperative Complications | 5 | 2026 | 2821 | 0.330 |
Why?
| | Humans | 36 | 2026 | 141754 | 0.310 |
Why?
| | Infant | 12 | 2026 | 9843 | 0.290 |
Why?
| | Lung | 1 | 2022 | 4137 | 0.290 |
Why?
| | Male | 23 | 2026 | 70179 | 0.280 |
Why?
| | Intestinal Mucosa | 5 | 2017 | 632 | 0.280 |
Why?
| | Suture Techniques | 2 | 2026 | 128 | 0.270 |
Why?
| | Liver Neoplasms | 2 | 2024 | 741 | 0.270 |
Why?
| | Female | 22 | 2026 | 75943 | 0.260 |
Why?
| | Length of Stay | 4 | 2025 | 1263 | 0.260 |
Why?
| | Clinical Protocols | 2 | 2025 | 273 | 0.260 |
Why?
| | Adolescent | 12 | 2026 | 22130 | 0.260 |
Why?
| | Gastropexy | 1 | 2026 | 4 | 0.240 |
Why?
| | Receptor, IGF Type 1 | 2 | 2017 | 64 | 0.240 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2017 | 22 | 0.240 |
Why?
| | Intercostal Nerves | 1 | 2025 | 2 | 0.240 |
Why?
| | Retinoblastoma Protein | 2 | 2017 | 59 | 0.240 |
Why?
| | Hypesthesia | 1 | 2025 | 20 | 0.230 |
Why?
| | Gastroschisis | 1 | 2025 | 33 | 0.230 |
Why?
| | Child, Preschool | 9 | 2026 | 11512 | 0.230 |
Why?
| | Sutures | 1 | 2025 | 60 | 0.230 |
Why?
| | Cryosurgery | 1 | 2025 | 48 | 0.230 |
Why?
| | Chemokine CXCL5 | 2 | 2015 | 12 | 0.220 |
Why?
| | Digestive System Abnormalities | 1 | 2024 | 20 | 0.220 |
Why?
| | Anastomotic Leak | 1 | 2024 | 43 | 0.220 |
Why?
| | Trisomy 18 Syndrome | 1 | 2024 | 5 | 0.220 |
Why?
| | Esophageal Atresia | 1 | 2024 | 26 | 0.220 |
Why?
| | Intestinal Volvulus | 1 | 2024 | 23 | 0.220 |
Why?
| | Tracheoesophageal Fistula | 1 | 2024 | 33 | 0.220 |
Why?
| | Hospitals, Pediatric | 2 | 2025 | 532 | 0.210 |
Why?
| | Competency-Based Education | 1 | 2025 | 75 | 0.210 |
Why?
| | Laparoscopy | 2 | 2026 | 463 | 0.210 |
Why?
| | Gastric Fistula | 1 | 2024 | 9 | 0.210 |
Why?
| | Critical Pathways | 1 | 2025 | 106 | 0.210 |
Why?
| | Pandemics | 2 | 2022 | 1656 | 0.190 |
Why?
| | Trauma Centers | 2 | 2024 | 450 | 0.190 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2023 | 21 | 0.190 |
Why?
| | Postoperative Care | 1 | 2025 | 280 | 0.190 |
Why?
| | Enoxaparin | 1 | 2023 | 67 | 0.190 |
Why?
| | Perioperative Care | 1 | 2025 | 227 | 0.190 |
Why?
| | Preoperative Care | 1 | 2024 | 372 | 0.180 |
Why?
| | Tomography, X-Ray Computed | 2 | 2023 | 2765 | 0.180 |
Why?
| | Interviews as Topic | 1 | 2025 | 854 | 0.180 |
Why?
| | False Positive Reactions | 1 | 2022 | 125 | 0.180 |
Why?
| | Scalp | 1 | 2021 | 35 | 0.180 |
Why?
| | Prospective Studies | 3 | 2025 | 7777 | 0.170 |
Why?
| | Fellowships and Scholarships | 1 | 2025 | 323 | 0.170 |
Why?
| | Photography | 1 | 2021 | 115 | 0.170 |
Why?
| | Intestinal Obstruction | 1 | 2021 | 53 | 0.170 |
Why?
| | Guideline Adherence | 1 | 2025 | 566 | 0.170 |
Why?
| | Operating Rooms | 1 | 2022 | 146 | 0.170 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2024 | 353 | 0.160 |
Why?
| | Treatment Outcome | 5 | 2025 | 11181 | 0.160 |
Why?
| | Healthcare Disparities | 2 | 2024 | 673 | 0.160 |
Why?
| | Education, Medical, Graduate | 1 | 2025 | 526 | 0.160 |
Why?
| | Transgender Persons | 1 | 2023 | 200 | 0.160 |
Why?
| | Pregnancy Outcome | 1 | 2023 | 457 | 0.160 |
Why?
| | Incidence | 2 | 2026 | 2806 | 0.160 |
Why?
| | Patient Education as Topic | 1 | 2025 | 779 | 0.160 |
Why?
| | Thrombosis | 1 | 2023 | 399 | 0.150 |
Why?
| | Neuroblastoma | 2 | 2011 | 163 | 0.150 |
Why?
| | Mice, Knockout | 5 | 2017 | 3071 | 0.140 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 589 | 0.140 |
Why?
| | Qualitative Research | 1 | 2025 | 1547 | 0.140 |
Why?
| | Feasibility Studies | 1 | 2022 | 1027 | 0.130 |
Why?
| | Patient Satisfaction | 1 | 2021 | 697 | 0.130 |
Why?
| | Infant, Premature | 1 | 2021 | 598 | 0.130 |
Why?
| | Sensitivity and Specificity | 1 | 2022 | 1977 | 0.130 |
Why?
| | Clinical Competence | 1 | 2025 | 1205 | 0.130 |
Why?
| | Curriculum | 1 | 2023 | 1039 | 0.130 |
Why?
| | Pediatrics | 1 | 2025 | 1100 | 0.130 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 884 | 0.130 |
Why?
| | Head and Neck Neoplasms | 1 | 2021 | 555 | 0.120 |
Why?
| | Parents | 1 | 2025 | 1440 | 0.120 |
Why?
| | Burnout, Professional | 1 | 2022 | 459 | 0.120 |
Why?
| | Mice, Inbred C57BL | 6 | 2015 | 5909 | 0.110 |
Why?
| | Intestinal Absorption | 1 | 2015 | 92 | 0.110 |
Why?
| | Enterocytes | 1 | 2014 | 16 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1866 | 0.110 |
Why?
| | Vitamin K Deficiency Bleeding | 1 | 2013 | 4 | 0.100 |
Why?
| | Extracorporeal Circulation | 1 | 2013 | 15 | 0.100 |
Why?
| | Digestive System Surgical Procedures | 1 | 2014 | 110 | 0.100 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2013 | 34 | 0.100 |
Why?
| | Dietary Proteins | 1 | 2014 | 136 | 0.100 |
Why?
| | Body Composition | 2 | 2014 | 703 | 0.100 |
Why?
| | Caregivers | 1 | 2021 | 943 | 0.100 |
Why?
| | Intracranial Hemorrhages | 1 | 2013 | 94 | 0.100 |
Why?
| | Diet, High-Fat | 1 | 2014 | 253 | 0.090 |
Why?
| | ErbB Receptors | 1 | 2015 | 610 | 0.090 |
Why?
| | Weight Gain | 1 | 2014 | 539 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2011 | 66 | 0.080 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2017 | 346 | 0.080 |
Why?
| | Imidazoles | 1 | 2011 | 255 | 0.080 |
Why?
| | Pregnancy | 1 | 2023 | 7092 | 0.080 |
Why?
| | Angiogenesis Inhibitors | 1 | 2011 | 230 | 0.080 |
Why?
| | Neovascularization, Pathologic | 1 | 2011 | 296 | 0.080 |
Why?
| | Patient Readmission | 2 | 2025 | 708 | 0.070 |
Why?
| | Piperazines | 1 | 2011 | 373 | 0.070 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2011 | 554 | 0.070 |
Why?
| | Animals | 9 | 2017 | 37749 | 0.070 |
Why?
| | Bacteria | 1 | 2014 | 881 | 0.070 |
Why?
| | RNA | 1 | 2014 | 930 | 0.070 |
Why?
| | Enteral Nutrition | 2 | 2023 | 202 | 0.060 |
Why?
| | Microbiota | 1 | 2014 | 768 | 0.060 |
Why?
| | Neoplasm Proteins | 1 | 2009 | 434 | 0.060 |
Why?
| | Thoracic Wall | 1 | 2025 | 20 | 0.060 |
Why?
| | Selenium | 1 | 2025 | 49 | 0.060 |
Why?
| | Cellulitis | 1 | 2025 | 55 | 0.060 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2011 | 913 | 0.060 |
Why?
| | Mice | 7 | 2017 | 18109 | 0.060 |
Why?
| | Postoperative Period | 2 | 2017 | 361 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2608 | 0.050 |
Why?
| | Thoracoscopy | 1 | 2024 | 58 | 0.050 |
Why?
| | Antibiotic Prophylaxis | 1 | 2025 | 122 | 0.050 |
Why?
| | Anastomosis, Surgical | 1 | 2024 | 159 | 0.050 |
Why?
| | Random Allocation | 2 | 2014 | 367 | 0.050 |
Why?
| | Disease Models, Animal | 4 | 2014 | 4421 | 0.050 |
Why?
| | Shock | 1 | 2024 | 103 | 0.050 |
Why?
| | Intubation, Gastrointestinal | 1 | 2024 | 77 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2009 | 1158 | 0.050 |
Why?
| | Gender Identity | 1 | 2023 | 127 | 0.050 |
Why?
| | Reoperation | 1 | 2025 | 592 | 0.050 |
Why?
| | Injury Severity Score | 1 | 2024 | 560 | 0.050 |
Why?
| | Disposable Equipment | 1 | 2022 | 23 | 0.050 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2025 | 270 | 0.050 |
Why?
| | Heparin | 1 | 2023 | 259 | 0.050 |
Why?
| | Adenoidectomy | 1 | 2022 | 73 | 0.040 |
Why?
| | Contrast Media | 1 | 2024 | 470 | 0.040 |
Why?
| | Adhesives | 1 | 2021 | 14 | 0.040 |
Why?
| | Hospital Costs | 1 | 2022 | 122 | 0.040 |
Why?
| | United States | 3 | 2024 | 15310 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2023 | 269 | 0.040 |
Why?
| | Tissue Adhesions | 1 | 2021 | 33 | 0.040 |
Why?
| | Cell Proliferation | 3 | 2015 | 2506 | 0.040 |
Why?
| | Intestines | 1 | 2023 | 357 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2014 | 1739 | 0.040 |
Why?
| | Medicaid | 1 | 2024 | 451 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2024 | 1317 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1826 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 5974 | 0.040 |
Why?
| | Young Adult | 2 | 2026 | 13749 | 0.040 |
Why?
| | Databases, Factual | 1 | 2024 | 1448 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2014 | 2828 | 0.030 |
Why?
| | Apoptosis | 2 | 2015 | 2576 | 0.030 |
Why?
| | Glucose Transporter Type 2 | 1 | 2014 | 15 | 0.030 |
Why?
| | Sodium-Glucose Transporter 1 | 1 | 2014 | 11 | 0.030 |
Why?
| | Fish Oils | 1 | 2014 | 26 | 0.030 |
Why?
| | Tissue and Organ Harvesting | 1 | 2014 | 74 | 0.030 |
Why?
| | Tamoxifen | 1 | 2014 | 203 | 0.030 |
Why?
| | Microcirculation | 1 | 2014 | 150 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2024 | 5697 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 1183 | 0.020 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2014 | 142 | 0.020 |
Why?
| | Colorado | 1 | 2023 | 4629 | 0.020 |
Why?
| | Cell Line, Tumor | 2 | 2011 | 3495 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 858 | 0.020 |
Why?
| | Blotting, Western | 1 | 2014 | 1234 | 0.020 |
Why?
| | Energy Intake | 1 | 2014 | 513 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 860 | 0.020 |
Why?
| | Bevacizumab | 1 | 2011 | 139 | 0.020 |
Why?
| | Risk Factors | 1 | 2024 | 10482 | 0.020 |
Why?
| | Mice, Nude | 1 | 2011 | 691 | 0.020 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 288 | 0.020 |
Why?
| | Adult | 2 | 2023 | 39391 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 151 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 175 | 0.020 |
Why?
| | Down-Regulation | 1 | 2011 | 641 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 184 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2015 | 1114 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2011 | 676 | 0.020 |
Why?
| | Weight Loss | 1 | 2014 | 791 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2011 | 907 | 0.020 |
Why?
| | Transfection | 1 | 2009 | 943 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2011 | 529 | 0.020 |
Why?
| | Base Sequence | 1 | 2009 | 2180 | 0.010 |
Why?
| | Biomarkers | 1 | 2017 | 4190 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2014 | 5212 | 0.010 |
Why?
| | Phosphorylation | 1 | 2009 | 1774 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2929 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2011 | 1435 | 0.010 |
Why?
| | Computational Biology | 1 | 2009 | 664 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2009 | 4212 | 0.010 |
Why?
|
|
Diaz-Miron's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|